Showing 5521-5530 of 5643 results for "".
- Genentech Unveils New Clinical Data For the First Eye Implant for Wet AMDhttps://modernod.com/news/genentech-unveils-positive-phase-2-results-for-the-first-eye-implant-for-wet-amd/2479987/Genentech announced positive topline results from the phase 2 LADDER study evaluating the efficacy and safety of its investigational Port Delivery System (PDS) with ranibizumab in people with wet age-related macular degeneration (AMD). The small, refillable eye implant, which is slightly l
- Rayner’s New UK-Based Manufacturing Facility Receives FDA Approvalhttps://modernod.com/news/rayners-new-uk-based-manufacturing-facility-receives-fda-approval/2479988/The FDA has approved Rayner’s Ridley Innovation Centre, a $40 million purpose-built R&D, training and production facility in Worthing, UK, according to a company news release. This state-of-the-art, dedicated IOL production center has the capability of manufacturing 3 million IOLs each
- EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gelhttps://modernod.com/news/eyegate-announces-fda-approval-of-two-ide-submissions-for-ocular-bandage-gel/2479995/EyeGate Pharmaceuticals announced the FDA has approved two of EyeGate’s investigational device exemption (IDE) applications for pilot studies of the company’s Ocular Bandage Gel (OBG) product for the acceleration of reepithelialization of large corneal epithelial defects in patients having underg
- Thomas A. Finley, MD, Appointed Chairmen of Ocutrx International Medical Advisory Boardhttps://modernod.com/news/thomas-a-finley-md-appointed-chairmen-of-ocutrx-international-medical-advisory-board/2479996/Ocutrx Vision Technologies, a California-based augmented reality (AR) glasses developer announced that Thomas A. Finley, MD, will serve as the Chairman of the Ocutrx International Medical Advisory Board (IMAB). The board serves to advise Ocutrx in its development of augmented reality glasses for
- Alcon Unveils Next-Generation Forceps to Improve Precision and Reduce Trauma During Retina Surgeryhttps://modernod.com/news/alcon-unveils-next-generation-forceps-to-improve-precision-and-reduce-trauma-during-retina-surgery/2479998/Alcon has launched the new Finesse Sharkskin ILM Forceps at the the American Society of Retina Specialists (ASRS) meeting. The next-generation tool is designed to provide increased surgical precision and to enhance retina surgery outcomes. The new forceps have a large grasping platform and a text
- FDA Releases Action Plan to Speed Up Market Entry for Biosimilarshttps://modernod.com/news/fda-releases-action-plan-to-speed-up-market-entry-for-biosimilars/2480010/The FDA unveiled plans Wednesday designed to facilitate the development, approval and market entry of biosimilars in the US. The Biosimilars Action Plan (BAP) “is aimed at promoting competition and affordability across the market for biologics and biosimilar products,” commented FDA C
- Bausch + Lomb Retina News, Eventshttps://modernod.com/news/bausch-lomb-retina-news-events/2480011/In advance of this week’s ASRS meeting, Bausch + Lomb Vice President and general manager of Surgical, Chuck Hess, distributed a customer letter to surgeons providing them an update on our progress in retina. The letter is below: Dear Eye Care Professional: At this time last y
- BlephEx Names Fred Ellis CEOhttps://modernod.com/news/blephex-names-fred-ellis-ceo/2480014/BlephEx has announced that Fred Ellis is the company’s new CEO. Mr. Ellis comes to BlephEx with 29+ years of experience with Alcon-Novartis. While there, he held numerous positions of increased responsibility overseeing a wide range of commercial assignments. He is recognized for having exception
- Sheraz Daya, MD, Introduces the Daya ICL Forcepshttps://modernod.com/news/sheraz-daya-md-introduces-the-daya-icl-forceps/2480015/In partnership with MST, Sheraz Daya, MD, has co-created an ICL loading system that ensures true confidence in loading and positioning. The design of the forceps allow the user to pull the ICL into the injection cartr
- LensGen Announces Funding And Patent Successhttps://modernod.com/news/lensgen-announces-funding-and-patent-success/2480017/LensGen, a private California company developing the world’s first modular, fluid-optic, curvature changing IOL, is reporting significant progress in its effort to transform how presbyopia is addressed, according to a company news release. The company successfully achieved a key clin